<DOC>
	<DOCNO>NCT02315131</DOCNO>
	<brief_summary>The primary objective study characterize safety profile duration bronchodilation single dose inhale TV46017</brief_summary>
	<brief_title>Study Healthy Volunteers COPD Patients Evaluate Efficacy Safety Inhaled TV46017</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Stage 1 Inclusion Criteria ( healthy volunteer ) : The subject male female 20 75 year age , inclusive , weigh 50 80 kg body mass index ( BMI ) less 30 kg/m2 . Note : Every effort make enroll approximately equal number men woman group . The subject good health determine medical psychiatric history , physical examination , electrocardiogram ( ECG ) , serum chemistry , hematology , urinalysis , serology . Other criterion apply , please contact investigator information Stage 2 Inclusion Criteria ( COPD patient ) : Current former cigarette smoker history cigarette smoke ≥10 pack year SV ( number cigarette pack smoke per day multiply number year smoke ; eg , 2 packs/day 3 year equal 6 pack year history ) . Diagnosis COPD define Global Initiative Chronic Obstructive Lung Disease guideline . Male female ; 40 75 year age , inclusive . Patient free medical condition concomitant treatment could interfere study conduct , influence interpretation study observations/results , put patient increase risk study . Other criterion apply , please contact investigator information Stage 1 Exclusion Criteria ( healthy volunteer ) : History current evidence clinically significant uncontrolled disease . Any disorder may interfere absorption , distribution , metabolism excretion study drug . History severe allergy milk protein . Active smoker former smoker quit within 3 month first dose study drug . Former smoker great fivepack year ( ie , equivalent one pack per day five year ) also exclude . Other criterion apply , please contact investigator information Stage 2 Exclusion Criteria ( COPD patient ) : Recent history hospitalization due exacerbation airway disease within 3 month . Need increase treatment COPD within 6 week prior SV . Occurrence COPD exacerbation , resolve 4 week prior SV/informed consent . ( Note : An exacerbation COPD define worsen patient 's baseline COPD symptoms require treatment rescue albuterol patient 's regular maintenance therapy . This include require use systemic corticosteroid , antibiotic , and/or emergency room visit hospitalization . ) History and/or current diagnosis asthma . Known α1 antitrypsin deficiency , active lung infection ( tuberculosis pneumonia ) , lung cancer absolute exclusionary condition . A patient , opinion investigator , significant respiratory condition addition COPD exclude . Examples may include clinically significant noncystic bronchiectasis , pulmonary hypertension , sarcoidosis , interstitial lung disease . Allergic rhinitis exclusionary . Other criterion apply , please contact investigator information</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>